Alabama drug injury Lawyer

Program Educates Healthcare Providers About Improper Drug Marketing

by Norris Injury Lawyers | November 5th, 2013

November 5, 2013

Advancements in medicine have saved countless lives, but the volume of drugs available on the market today can make choosing the correct medication confusing. The Birmingham Drug Injury Lawyers with Norris Injury Lawyers explain these difficulties are only exacerbated by the relentless marketing efforts that drug manufacturers use to push products on doctors and their patients.

Many drug companies market medications for conditions they are not intended to treat. This is called an “off-label” use of a drug. While the practice can be effective under certain circumstances, experts tend to agree that the risks outweigh the benefits.

This has prompted the U.S. Food and Drug Administration to hold a program aimed at teaching participants how to see through marketing strategies drug companies use to help sell medications. They will also learn where they can report misleading advertising.

The program will offer instruction to healthcare providers by providing them with educational videos and data gathered through numerous cases studies. Participants will also learn about the regulatory concerns involved with off-label uses of medications.

Norris Injury Lawyers and their team of Alabama Personal Injury Lawyers applaud the efforts being made to improve patient safety by training medical staff of the dangers improper usage of medications can cause and are hopeful the campaign help reduce injury numbers.


FDA Announces New Warnings for IV Antibiotic due to Increased Risk of Death

by Norris Injury Lawyers | October 1st, 2013

October 1, 2013

Drug makers are responsible for testing and ensuring the safety of the medications they bring to market. The Alabama Drug Injury Lawyers with Norris Injury Lawyers explain that warning labels on drug packaging must state any dangers drugs pose to consumers.

In response to new findings that show the intravenous version of the antibiotic Tygacil (Tygecycline) may increase users’ risk of death, the FDA has ordered the makers of the drug to update the product’s warning label.

According to a press release from the agency, Tygacil is used to treat different types of serious skin infections, as well as intra-abdominal infections and community-acquired bacterial pneumonia. Experts say that the drug should not be used unless alternative treatment methods are unavailable or unsuitable for patients.

These recommendations were made after researchers discovered that those who use Tygecycline-based products have an increased risk of death of as much as four percent. These deaths were the result of infections worsening, complications caused by infections, or other medical conditions.

Norris Injury Lawyers’ team of Alabama Personal Injury Lawyers points out that warnings like this one highlight the need for more citizens to be aware of the side effects of drugs they take.



Contamination Risks Spark Recall of Products From Three Compounding Pharmacies

by Norris Injury Lawyers | September 3rd, 2013

September 3, 2013

Last week, the U.S. Food and Drug Administration (FDA) announced it was issuing recalls on products manufactured at three different compounding facilities due to lack of sterility assurance. The Alabama Drug Injury Lawyers with Norris Injury Lawyers explain the string of recalls comes on the heels of a fungal meningitis outbreak that claimed dozens of lives and left hundreds of others sickened.

An FDA press release announced a recall on six specific medications manufactured by Wellness Pharmacy, Inc., in Birmingham on Friday. Reports indicate that investigators were conducting an inspection of the facility when they discovered practices that may have compromised the sterility of certain medications. The following day, similar discoveries were made at facilities in Loveland, Colorado, and Irvine, California.

Anyone in possession of the products affected by these three recalls have been instructed to halt use of the medications immediately and contact the FDA’s MedWatch program to report adverse health events associated with the affected products.

So far, nearly one dozen compounding facilities have faced similar scrutiny in the past several months over sterile manufacturing procedures.

Norris Injury Lawyers’ team of Alabama Personal Injury Lawyers recognizes the dangers using a potentially contaminated medication could have. That is why the firm would encourage anyone who has been injured by a recalled drug to discuss their legal rights with an attorney immediately.

Alabama Drug Injury Lawyers Discuss Workout Supplement Dangers

by Norris Injury Lawyers | August 20th, 2013

August 20, 2013

While workout supplements can be a great way to boost athletic performance, the Workout Supplement Injury Lawyers with Norris injury Lawyers point out how some of these products can present serious health risks.

In fact, the U.S. Food and Drug Administration (FDA) recently announced a voluntary recall of three products manufactured by Herbal Give Care LLC, based in Grand Prairie, Texas. Reports indicate the recalls were launched due to undeclared ingredients in the products that could result in consumers suffering serious adverse health events.

The recall affects Esbelder Fem, Man, and Silouette tablets that each come in containers holding 20 tablets. The medications are said to contain undeclared Sibutramine, N-Desmethylsibutramine, and N-di-Desmethylsibutramine. These chemicals have been linked to increased blood pressure and heart rate in users, which could lead to serious health problems for those who suffer from coronary artery disease, congestive heart failure, arrhythmias, or stroke.

Anyone in possession of the affected products should halt use and contact the manufacturer immediately to return the medications. The FDA suggests anyone who has been harmed by the products report their case to the agency’s MedWatch program.

Norris Injury Lawyers’ team of Alabama Personal Injury Lawyers would also suggest that anyone who has been harmed by a defective medication discuss their legal rights with an attorney. Doing so can help victims receieve proper compensation for their injury-related expenses.

FDA Announces Recall of Contaminated Medications

by Norris Injury Lawyers | June 4th, 2013

June 4, 2013

Last week, the U.S. Food and Drug Administration (FDA) announced the voluntary recall of all products manufactured by the Main Street Family Pharmacy, LLC. Reports indicate the recall was initiated due to contamination of medications that could lead to patients suffering serious Drug Injuries.

The recall stems from an investigation launched into several claims of patients sickened after receiving injections from three lots of preservative-free methylprednisolone acetate. Seven of the patients reported developing abscesses on their skin at the sight of the injection. Testing later determined that at least one of the abscesses was caused by a fungal infection.

Investigators determined the medications the patients had received were contaminated and out of precaution, requested that all sterile medications compounded at the facility be recalled to ensure patient safety.

The incident is similar to hundreds of cases associated with a Fungal Meningitis outbreak that claimed 55 lives and left 741 others sickened recently.

An FDA Press Release explained that patients who received medications manufactured at the facility should discuss their concerns with their physician. Those in possession of affected medications should contact Main Street Family Pharmacy for information on proper disposal of affected drugs and receiving replacement medications.

The Alabama Personal Injury Lawyers with Norris Injury Lawyers recognize the risks involved with the use of a contaminated medication. The firm may be able to help if such a drug has harmed you.

Lawsuit Filed in Connection with Granuflo Death

by Norris Injury Lawyers | March 12th, 2013

March 12, 2013

Just two weeks ago, an Alabama Wrongful death lawsuit was filed against the drug manufacturer Fresenius Medical Care. According to a story from Injury Lawyer News, the suit alleges the victim died as a result of taking the company’s products, Granuflo and Naturalyte.

The drugs are used to concentrate acid levels in the body. However, studies have shown they can cause high levels of serum bicarbonate to build in those undergoing hemodialysis. This can result in a number of adverse cardiovascular events including:

  • Metabolic alkalosis.
  • Hypokalemia.
  • Hypoxemia.
  • Hypercapnia.
  • Cardiac arrhythmia.
  • Cardiopulmonary arrest.
  • Death.

That was allegedly the case on Feb. 28, 2011, when the plaintiff’s husband suffered a fatal cardiovascular event while undergoing treatment. The suit explains that neither the woman nor her husband’s doctors had reason to believe the drugs were associated with the victim’s death until a recall was issued in 2012.

The Kidney Dialysis Injury Lawsuit went on to claim the manufacturer of the product was negligent in failing to warn consumers of the dangers associated with taking the drugs. The suit is seeking damages for burial and funeral expenses, medical bills, and emotional distress, along with punitive damages.

The Alabama Personal Injury Attorneys with Norris Injury Lawyers are hopeful a decision in the case will bring a sense of closure to the family of the victim.

Alabama Woman Files Drug Injury Lawsuit against Maker of Pradaxa

by Norris Injury Lawyers | January 15th, 2013

Jan. 15, 2013

A 70-year-old woman from Alabama filed a lawsuit against drug manufacturer, Boehringer Ingelheim Pharmaceuticals. The lawsuit claims she suffered massive internal bleeding after taking the company’s medication, Pradaxa. Injury Lawyer News reports that the victim also claims the company failed to properly warn consumers about dangers associated with taking Pradaxa.

The lawsuit states the victim began a regimen of Pradaxa in Dec. 2010 to decrease the chances of a stroke. By May 2011, the woman was suffering from “excessive and uncontrollable” gastrointestinal bleeding. She was taken off the drug and survived after receiving medical treatment, but never fully recovered.

The woman’s case is now part of a multidistrict litigation being heard in United States District Court. Attorneys for the victims claim Boehringer Ingelheim Pharmaceuticals knew, or should have known, about the risks of taking Pradaxa and failed to make the public aware of the risks.

The U.S. Food and Drug Administration has received several reports of deaths associated with internal bleeding associated with Pradaxa, and recently ordered the company to offer revised warning labels on drug packaging to help reduce the risk of injuries.

The Birmingham Personal Injury Lawyers with Norris Injury Lawyers know the dangers certain medications can pose to patients and suggest discussing your legal options with an attorney if you believe you may have suffered a Birmingham Drug Injury.


FDA Considers Making More Medications Available Over-The-Counter

by Norris Injury Lawyers | April 3rd, 2012

April 3, 2012

The United States is experiencing a problem of getting prescription medications to citizens who need them. While the reasons for the problem vary from drug shortages to rising costs, the Food and Drug Administration is asking for the public’s input on how it can solve the growing issue.

According to a press release issued by the agency, it’s considering making some prescription medications available over-the-counter. Some of the drugs may feature certain stipulations, such as discussing the medication with a pharmacist or passing a diagnostic test, but the goal is to make getting the medications into a patient’s hands easier.

Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research, supported the measure by saying, “The rules for nonprescription status were established in an age when widespread access to information technology did not exist. The world is evolving. It’s clear there are now many interactive mechanisms that can help consumers through the process of self-diagnosis and medication selection in a much more comprehensive manner than a few words on a fact box.”

While experts agree that the cut in health care costs far outweigh the negative ramifications that can be solved through regulation, others feel the change could bring unforeseen problems with record keeping, patient diagnosis, and liability concerns.

The Alabama Drug Injury Lawyers with Norris Injury Lawyers urge those taking medications to only use them as prescribed by their doctor.

Drug Shortages Tackled By New Executive Order

by Norris Injury Lawyers | November 1st, 2011

November 1, 2011

In an effort to relieve price-gouging and patient deaths across the country due to numerous drug shortages, President Barack Obama ordered the Food and Drug Administration (FDA) make immediate changes to their guidelines involving shortage reporting and application approval processes. According to CBS 42 News, the FDA will now require drug makers to give a six-month warning notice to patients before stopping the production of a drug.

An associate professor at Samford’s School of Pharmacy in Birmingham, Alabama, said she has seen the shortages cause price mark-ups of over 300 percent by grey market distributors in the area. The most common drugs on shortage are antibiotics and chemotherapy drugs.

Although the order was signed Monday, it will take time to stop what president Obama has called a rolling problem. He hopes more relief will come through a bill he proposed to Congress that would prevent future drug shortages.

The Alabama Drug Injury Attorneys with Norris Injury Lawyers know that drug shortages can happen, but they are no excuse for a patient to suffer because medical staff cant get their hands on the drugs they need. Contact them immediately by filling out a free initial consultation form if you have suffered because you could not get the drugs you needed.